Vinati Organics (VINATIORGA)₹1,067−0.39%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Vinati Organics reported sales of ₹679 Cr, up 23.7% from Sep 2025, and net profit of ₹78.23 Cr, down 32.2% year on year. For the year to Mar 2026, sales were ₹2,222 Cr and net profit ₹446 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 447 | 549 | 524 | 552 | 521 | 646 | 541 | 549 | 530 | 603 | 695 | 679 |
| Expenses | 332 | 399 | 399 | 419 | 379 | 467 | 381 | 383 | 374 | 434 | 524 | 554 |
| Operating Profit | 115 | 150 | 124 | 135 | 143 | 181 | 161 | 168 | 158 | 170 | 170 | 126 |
| OPM % | 26.0% | 27.1% | 24.0% | 24.0% | 27.0% | 28.0% | 29.0% | 30.0% | 30.0% | 28.0% | 24.0% | 18.0% |
| Other Income | 8.99 | 9.98 | 8.99 | 21.97 | 6.99 | 5.99 | 6.99 | 15.99 | 8.99 | 19.97 | 8.99 | 12.98 |
| Interest | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 19.08 | 20.06 | 21.08 | 22.09 | 22.08 | 23.07 | 26.09 | 26.09 | 29.10 | 30.12 | 32.11 | 33.14 |
| Profit before tax | 103 | 139 | 112 | 134 | 127 | 164 | 141 | 157 | 136 | 160 | 148 | 106 |
| Tax % | 25.0% | 25.0% | 25.1% | 22.0% | 26.0% | 25.0% | 26.1% | 27.0% | 26.0% | 23.0% | 26.0% | 26.0% |
| Net Profit | 77.20 | 104 | 84.26 | 104 | 94.25 | 123 | 104 | 115 | 101 | 124 | 109 | 78.23 |
| EPS (Rs) | 7.48 | 10.04 | 8.11 | 10.08 | 9.03 | 11.86 | 10.06 | 11.07 | 9.74 | 11.96 | 10.51 | 7.55 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,028 | 952 | 1,612 | 2,063 | 1,895 | 2,242 | 2,222 | 2,505 |
| Expenses | 613 | 601 | 1,178 | 1,491 | 1,427 | 1,663 | 1,571 | 1,886 |
| Operating Profit | 416 | 354 | 436 | 575 | 472 | 584 | 657 | 625 |
| OPM % | 40.0% | 37.1% | 27.1% | 28.1% | 25.1% | 26.0% | 29.0% | 24.9% |
| Other Income | 44.93 | 25.97 | 60.90 | 51.90 | 38.93 | 43.96 | 52.91 | 50.93 |
| Interest | 1.99 | 0.99 | 1.99 | 2.99 | 4.98 | 1.99 | 0.99 | 0.00 |
| Depreciation | 33.13 | 43.18 | 45.17 | 59.18 | 73.22 | 89.25 | 111 | 124 |
| Profit before tax | 424 | 334 | 448 | 561 | 431 | 535 | 594 | 548 |
| Tax % | 21.0% | 20.0% | 23.1% | 26.0% | 25.0% | 24.0% | 25.0% | — |
| Net Profit | 335 | 270 | 348 | 421 | 324 | 406 | 446 | 413 |
| EPS (Rs) | 32.49 | 26.21 | 33.73 | 40.79 | 31.14 | 39.05 | 42.81 | 39.76 |
| Dividend payout % | 17.0% | 23.1% | 19.0% | 17.0% | 22.0% | 19.0% | 20.1% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 9.96 | 9.97 | 9.97 | 9.96 | 9.97 | 9.97 | 9.97 |
| Reserves | 1,269 | 1,533 | 1,819 | 2,203 | 2,451 | 2,782 | 3,151 |
| Borrowings | 0.00 | 1.99 | 17.96 | 34.92 | 4.98 | 62.84 | 0.00 |
| Other Liabilities | 162 | 187 | 242 | 333 | 372 | 421 | 415 |
| Total Liabilities | 1,442 | 1,733 | 2,090 | 2,583 | 2,839 | 3,276 | 3,577 |
| Fixed Assets | 750 | 756 | 872 | 1,158 | 1,489 | 1,721 | 2,119 |
| CWIP | 30.87 | 55.76 | 50.77 | 241 | 248 | 436 | 213 |
| Investments | 226 | 288 | 93.62 | 226 | 63.80 | 35.86 | 189 |
| Other Assets | 435 | 633 | 1,072 | 957 | 1,038 | 1,082 | 1,054 |
| Inventories | 93.24 | 122 | 176 | 234 | 200 | 222 | 312 |
| Trade receivables | 203 | 278 | 459 | 464 | 531 | 593 | 522 |
| Cash & equivalents | 54.18 | 7.02 | 4.01 | 13.04 | 13.05 | 4.01 | 6.02 |
| Total Assets | 1,442 | 1,733 | 2,090 | 2,583 | 2,839 | 3,276 | 3,577 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 417 | 220 | 127 | 516 | 333 | 459 | 559 |
| Cash from investing activity | −197 | −198 | −255 | −329 | −348 | −443 | −414 |
| Cash from financing activity | −109 | −2.99 | −46.87 | −61.79 | −108 | −15.94 | −140 |
| Net cash flow | 109 | 17.95 | −174 | 124 | −125 | 0.00 | 2.99 |
| Capex | 310 | 49.06 | 162 | 344 | 398 | 500 | 270 |
| Free cash flow | 279 | 136 | −47.11 | 201 | −65.16 | −39.08 | 288 |
| CFO / OP % | 124.0% | 78.9% | 53.9% | 113.0% | 88.9% | 94.9% | 105.9% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 73 | 107 | 105 | 83 | 103 | 97 | 86 |
| Inventory days | 79 | 115 | 75 | 79 | 72 | 68 | 110 |
| Days payable | 46 | 62 | 45 | 40 | 35 | 44 | 42 |
| Cash conversion cycle | 103 | 157 | 131 | 119 | 136 | 117 | 151 |
| Working capital days | 98 | 139 | 138 | 110 | 142 | 116 | 131 |
| ROCE % | — | 24.0% | 27.0% | 28.0% | 19.1% | 20.0% | 20.0% |
For the Sep 2026 quarter, Vinati Organics reported sales of ₹679 Cr, up 23.7% year on year and net profit of ₹78.23 Cr, down 32.2% year on year. The operating margin was 18.0%.
Vinati Organics' sales for the year to Mar 2026 were ₹2,222 Cr; over the last twelve months they were ₹2,505 Cr.
Net profit for the year to Mar 2026 was ₹446 Cr, and ₹413 Cr over the last twelve months. Earnings per share over the same trailing period were ₹39.76.
Vinati Organics reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹6.02 Cr.
Cash from operations was ₹559 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹288 Cr.